References
Rutherford RB, Johnston KW. Potential problems with industry-supported research. J Vasc Surg 2000;31:1066–1076.
Weatherall D. Academia and industry: Increasingly uneasy bedfellows. Lancet 2000;355:1574.
Angell M. Is academic medicine for sale? N Engl J Med 2000;342:1516–1518.
Bodenheimer T. Uneasy alliance—clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539–1544.
Goldstein LB, Brott TG, Kothari RU, Smith WS. Clinical stroke trials: Guarding against bias. Stroke 1999;30:1 165–1166.
Hailey D. Scientific harassment by pharmaceutical companies. Time to stop. CMAJ 2000;162:212–213.
Renni D. Fair conduct and fair reporting of clinical trials. JAMA 1999;282:1766–1768.
Kahn JO, Cheng DW, Mayer K, Murray H, Lagakos S. Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 × 106/L CD4 cell counts: A randomized controlled trial. JAMA 2000;284:2193–2202.
Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science. Evidence from a national survey of faculty. JAMA 1997;277:1224–1228.
Rutherford RB, Johnston KW. Protecting the rights of investigators in industry supported clinical research. J Vasc Surg (in press).
Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L. et al. Sponsorship, authorship, and accountability. N Engl J Med 2001;345:825.
Rights and permissions
About this article
Cite this article
Investigators’ responsibilities and rights. J Gastrointest Surg 6, 512–513 (2002). https://doi.org/10.1016/S1091-255X(02)00031-8
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(02)00031-8